Glide sheath
Product overview
Expanding trans-radial access to include more patients
- Glide sheath Slender is designed with a proprietary thin-wall technology where the outside diameter is reduced by one French size while the inner-diameter equivalent is maintained.
- Glide sheath Slender is coated with Terumo’s proprietary hydrophilic coating, allowing for smooth insertion and removal.
Features and Benefits
The proprietary thin-wall technology and Terumo M Coat hydrophilic coating
- Per the American Heart Association, dedicated radial sheaths with hydrophilic coating combined with smaller diameter sheaths and a tapered tip design may reduce risk of arterial spasm and radial occlusion1
- Featuring Terumo’s proprietary hydrophilic coating, the Glide sheath Slender Sheath is the only thin-wall radial sheath on the market to demonstrate superior and consistent performance in lubricity and durability over time
The Glide sheath Slender Sheath is the only thin-wall sheath that demonstrated best in class performance in all of the American Heart Association’s identified critical features that lead to reduced spasm.
THE POWER OF TERUMO GLIDE TECHNOLOGY™: LUBRICITY OVER TIMES
Hydrophilic coating is critical to procedural success, Physicians need to trust that their sheath will be just as lubricous at the end of case as it is at the beginning.
The graph below demonstrates the results of recent benchtop testing. The lower the value, the more lubricious the coating. The straighter the line, the more consistent, and reliable, the performance.
Glide sheath Slender Sheath outperformed the other competitive sheaths in both key features: lubricity and lubricity over time.
Unmatched Clinical Evidence
- A meta-analysis of 10 clinical papers, involving 3,821 patients, demonstrated that use of Glide sheath Slender Sheath is associated with high rates of procedural success and low rates in performance related issues.
- In studies measuring patient comfort, patients who underwent percutaneous trans-radial procedures with the Glide sheath Slender Sheath reported none to low amounts of pain.
Related products
-
SPRINTER LEGEND PTCA BALLOON
SPRINTER LEGEND 1.25 BALLOON CATHETER
Super Crosser Semi compliant Balloon Dilatation Catheter (RX/OTW)
Sprinter™ Legend™ 1.25 SuperCrosser semicompliant balloon dilatation catheter delivers exceptional crossability to treat today’s challenging lesions.
With innovative crossing technologies and 57 sizes, the Sprinter™ Legend™ RX semicompliant balloon dilatation catheter provides you with the power to cross.
OVERVIEW
During difficult cases, reach for a slim Sprinter™ Legend™ 1.25 mm Super Crosser semi compliant coronary balloon catheter featuring:
- Award-winning* Zerofold technology — no wrapped material and no balloon shoulders
- Low 0.5 mm (0.020 in) crossing profile
- OTW and RX platforms
ORDERING INFORMATION
BALLOON LENGTHS 6, 10, 12, AND 15 MM
1.25 SPL12506WL SPL12510WL SPL12515WL SPL12520WL -
RESOLUTE INTEGRITY STENT
Resolute Onyx DES
for coronary artery disease
Resolute Onyx™ is a drug-eluting stent (DES) that’s different by design, optimised for complex PCI, and proven safe and effective in real-world, high bleeding risk patients on 1-month dual antiplatelet therapy (DAPT).1
Resolute Onyx DES is different by design to address your DES needs and a wide range of patient anatomies. It features:
- Best-in-class deliver ability
- Enhanced visibility with thinner struts
- Smooth side branch access
- Fast healing
- The broadest diameter range
Best-in-class deliverability
Single-wire design
Resolute Onyx DES is made from a single wire, which gives it a fluid range of motion and provides the flexibility needed for best-in-class deliverability.2
Sinusoid-formed wire
Helical wrap
Laser-fused
Competitive comparison
Resolute Onyx DES is more deliverable than laser-cut SYNERGY™* XD and XIENCE Skypoint™*, which are stiffer.
Deliverability comparison — 3.0 mm DES2
(Lower is better)
Enhanced visibility with thinner struts
Platinum-iridium core within Resolute Onyx DES increases visibility for accurate stent placement without compromising strut thickness.2Average visibility comparison2
(Higher is better)
- Cobalt alloy shell
- Platinum iridium core
Resolute Onyx cobalt alloy shell and platinum-iridum core
Smooth side branch access
Resolute Onyx DES has round struts to create a smooth passage when accessing the side branch and lower the propensity to catch during bifurcation procedures.2
Strut comparison
Rounded strut cross-section
- Resolute Onyx DES
Square strut cross-section
- SYNERGY™* DES
- XIENCE™* DES
Broadest diameter range
- Complex PCI requires a broad DES size matrix to match a wide range of patient anatomies.
- Resolute Onyx is the only DES with diameters ranging from 2.0 mm to 5.0 mm to treat a broad range of coronary vessel sizes.
Diameter (mm) Stent Length (mm) Maximum Expansion
Capabilities (MSID†) (mm)2.00 8 12 15 18 22 26 30 — — 3.50‡ 2.25 8 12 15 18 22 26 30 34 38 3.50‡ 2.50 8 12 15 18 22 26 30 34 38 3.50‡ 2.75 8 12 15 18 22 26 30 34 38 4.00‡ 3.00 8 12 15 18 22 26 30 34 38 4.00‡ 3.50 8 12 15 18 22 26 30 34 38 5.00‡ 4.00 8 12 15 18 22 26 30 34 38 5.00‡ 4.50 — 12 15 18 22 26 30 — — 6.00‡ 5.00 — 12 15 18 22 26 30 — — 6.00‡ PRODUCT DETAILS
2.00 RONYX20008X RONYX20012X RONYX20015X RONYX20018X RONYX20022X RONYX20026X RONYX20030X N/A N/A 2.25 RONYX22508X RONYX22512X RONYX22515X RONYX22518X RONYX22522X RONYX22526X RONYX22530X RONYX22534X RONYX22538X 2.50 RONYX25008X RONYX25012X RONYX25015X RONYX25018X RONYX25022X RONYX25026X RONYX25030X RONYX25034X RONYX25038X 2.75 RONYX27508X RONYX27512X RONYX27515X RONYX27518X RONYX27522X RONYX27526X RONYX27530X RONYX27534X RONYX27538X 3.00 RONYX30008X RONYX30012X RONYX30015X RONYX30018X RONYX30022X RONYX30026X RONYX30030X RONYX30034X RONYX30038X 3.50 RONYX35008X RONYX35012X RONYX35015X RONYX35015X RONYX35022X RONYX35026X RONYX35030X RONYX35034X RONYX35038X 4.00 RONYX40008X RONYX40012X RONYX40015X RONYX40018X RONYX40022X RONYX40026X RONYX40030X RONYX40034X RONYX40038X 4.50 N/A RONYX45012X RONYX45015X RONYX45018X RONYX45022X RONYX45026X RONYX45030X N/A N/A 5.00 N/A RONYX50012X RONYX50015X RONYX50018X RONYX50022X RONYX50026X RONYX5 -
Coronary Diagnostic Catheter (OPTITORQUE)
PRODUCT OVERVIEW
A complete line of coronary diagnostic catheters designed for superior torque control and precise placement.
RADIAL-SPECIFIC UNIVERSAL SHAPES
- Radial Specific curves designed to enable support and alignment during catheterization1
- Excellent back-up support for angiography of both RCA and LCA with a single catheter1,a
- Universal design eliminates the need for catheter exchanges and potentially shortens procedural and fluoroscopic time
1. DOF Reference
a. when compared to leading competitors
2. Ikaria article.OPTITORQUE Classic Shapes
Shape Category Product Code
5 Fr / 1.70 mmProduct Code
6 Fr / 2.00 mmShape Name (cm) Length Holes Side Tip Shape Pigtail 40-5030 40-6030 Straight Pigtail 110 6 40-5031 40-6031 Angled Pigtail 155° 110 6 Judkins Left 40-5040 40-6040 JL 3.5 (Judkins Left 3.5 cm) 100 40-5041 40-6041 JL 4.0 (Judkins Left 4.0 cm) 100 40-5042 40-6042 JL 5.0 (Judkins Left 5.0 cm) 100 Judkins Right 40-5043 40-6043 JR 3.5 (Judkins Right 3.5 cm) 100 40-5044 40-6044 JR 4.0 (Judkins Right 4.0 cm) 100 40-5045 JR 5.0 (Judkins Right 5.0 cm) 100 Bypass 40-5050 40-6050 Internal Mammary 100 Amplatz 40-5060 AL 1 (Amplatz Left Small Type) 100 40-5061 40-6061 AL 2 (Amplatz Left Middle Type) 100 UNIQUE DESIGN
- Designed for coaxial alignment to the ostium, allowing the catheter to sit at the appropriate angle for optimal engagement
- Large lumen allows high flow of contrast media and allows downsizing of French size
PROVEN PERFORMANCE
- Superior torqueability for precise placement1,a
- Excellent trackability in tortuous anatomy while navigating the radial artery1,a
- Superior flow rates for diagnostic imaging1,a
1.DOF
a. When compared to leading competitors -
GUIDING CATHETER EKARI
Product Overview
IMPROVED BACK UP SUPPORT*1
Catheter designed to use contralateral wall resulting in enhanced back-up support.
UNIVERSAL SHAPE (IKARI LEFT) *2
Offer capability of accessing the right and left coronary arteries, potentially avoiding catheter exchanges.
DESIGN FOR SAFETY
Soft tip to reduce damage to the vessel wall
*1: Ikari Y, Nagaoka M, Kim JY, Merino Y, Tanabe T. The physics of guiding catheters for the left coronary artery in transfemoral and trans-radial interventions. J Invasive Cardio. 2005 Dec; 17(12): 636-641.*2: Youssef AA, Hsieh YK, Cheng CI, We CJ. A single trans-radial guiding catheter for right and left coronary angiography and intervention. Euro intervention 2007; 3: 475-481.
Patients who have had cardiac catheterization or coronary angioplasty often are required to stay in bed with restricted movement for three to 24 hours afterward to prevent bleeding from the femoral artery catheter insertion site.
Features and Benefits
Improved back up support in comparison to Terumo standard femoral guiding catheter shapes*1
*1: Based on comparative studies made among Terumo Guiding Catheters*2: Ekari Y, Nagaoka M, Kim JY, Merino Y, Tanabe T. The physics of guiding catheters for the left coronary artery in transfemoral and trans-radial interventions. J Invasive Cardio. 2005 Dec; 17(12): 636-641.*3: Youssef AA, Hsieh YK, Cheng CI, We CJ. A single trans-radial guiding catheter for right and left coronary angiography and intervention. Euro intervention 2007; 3: 475-481.
Guide catheters are required for all coronary interventions to provide access to the coronary ostium and support equipment delivery. The ideal guide provides stability for device advancement through the coronary anatomy, while minimizing vessel trauma and allowing for vessel opacification.
The catheter is guided to the narrowed artery. Then, a smaller balloon catheter is inserted through the flexible catheter and inflated at the narrowed area to open it. Often, the doctor will also place a mesh coil called a stent at the narrowed part to help keep the artery open.
Quiernera –
Relative mCherry was calculated by normalizing to the WT untreated average cell value generic priligy online
Quiernera –
[url=https://fastpriligy.top/]priligy review youtube[/url] Given these data, women diagnosed with breast cancer should use hormones sparingly